United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 397,697 | 284,258 | 154,030 | 162,676 | 252,162 |
| Marketable Securities | 297,842 | 409,645 | 325,175 | 240,803 | 374,921 |
| Receivables | 162,287 | 126,297 | 116,626 | 88,680 | 73,707 |
| Inventories | 66,927 | 47,758 | 37,254 | 45,981 | 35,520 |
| Income taxes - deferred | N/A | N/A | N/A | 8,199 | 12,585 |
| Other current assets | 32,836 | 46,424 | 35,385 | 6,188 | 6,840 |
| TOTAL | $957,589 | $914,382 | $668,470 | $562,455 | $764,487 |
| Non-Current Assets | |||||
| PPE Net | 478,421 | 464,950 | 453,685 | 366,046 | 306,044 |
| Investments And Advances | 122,658 | 448,134 | 311,103 | 349,022 | 137,971 |
| Intangibles | 29,465 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 296,277 | 260,101 | 193,337 | 240,556 | 223,133 |
| TOTAL | $926,821 | $1,173,185 | $958,125 | $955,624 | $667,148 |
| Total Assets | $1,884,410 | $2,087,567 | $1,626,595 | $1,518,079 | $1,431,635 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 126,414 | 282,459 | 1,291 | N/A | 235,968 |
| Accounts payable and accrued liabilities | 85,382 | 92,244 | 10,203 | 47,257 | 16,146 |
| Accrued Expenses | N/A | N/A | 72,985 | 57,227 | 50,280 |
| Other current liabilities | 292,514 | 312,971 | 92,276 | 108,093 | 126,292 |
| TOTAL | $504,310 | $687,674 | $176,755 | $212,577 | $428,686 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 70,343 | 71,452 | 68,929 |
| Other Non-Current Liabilities | 137,744 | 140,619 | 295,516 | 285,562 | 50,134 |
| TOTAL | $137,744 | $140,619 | $365,859 | $357,014 | $119,063 |
| Total Liabilities | $642,054 | $828,293 | $542,614 | $569,591 | $547,749 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,666 | 50,477 | 50,183 | 53,627 | 57,754 |
| Common Shares | 660 | 630 | 621 | 615 | 600 |
| Retained earnings | 1,068,114 | 728,040 | 553,480 | 249,038 | 31,170 |
| Other shareholders' equity | -16,559 | -13,620 | -14,955 | -10,883 | -9,574 |
| TOTAL | $1,242,356 | $1,259,274 | $1,083,981 | $948,488 | $883,886 |
| Total Liabilities And Equity | $1,884,410 | $2,087,567 | $1,626,595 | $1,518,079 | $1,431,635 |